Skip to main content
SpringerLink
Log in

Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis

  • Short Communication
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chen SC, Slavin M, Sorrell TC (2011) Echinocandin antifungal drugs in fungal infections. Drugs 71:11–41

    Article  PubMed  CAS  Google Scholar 

  2. Caspofungin acetate. European Public Assessment Report—Scientific Discussion. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000379/WC500057186.pdf. Accessed 28 Dec 2010

  3. Spriet I, Annaert P, Meersseman P et al (2009) Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation. J Antimicrob Chemother 63:767–770

    Article  PubMed  CAS  Google Scholar 

  4. Mistry GC, Migoya E, Deutsch PJ et al (2007) Single- and multiple-dose administration of caspofungin in patients with hepatic insufficiency: implications for safety and dosing recommendations. J Clin Pharmacol 47:951–961

    Article  PubMed  CAS  Google Scholar 

  5. Stone JA, Holland SD, Wickersham PJ et al (2002) Single-and multiple dose pharmacokinetics of caspofungin in healthy men. Antimicrob Agents Chemother 46:739–45

    Article  PubMed  CAS  Google Scholar 

  6. Nguyen TH, Hoppe-Tichy T, Geiss HK et al (2007) Factors influencing caspofungin plasma concentrations in patients of a surgical intensive care unit. J Antimicrob Chemother 60:100–106

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Pharmacy Department, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium

    Isabel Spriet & Ludo Willems

  2. General Internal Medicine, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium

    Wouter Meersseman

  3. Laboratory of Biopharmacy and Pharmacotechnology, Faculty of Pharmaceutical Sciences, Catholic University Leuven, Herestraat 49, 3000, Leuven, Belgium

    Pieter Annaert

  4. Centre for Clinical Pharmacology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium

    Jan de Hoon

Authors
  1. Isabel Spriet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wouter Meersseman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pieter Annaert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jan de Hoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ludo Willems
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Isabel Spriet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spriet, I., Meersseman, W., Annaert, P. et al. Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis. Eur J Clin Pharmacol 67, 753–755 (2011). https://doi.org/10.1007/s00228-011-1066-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-011-1066-8

Keywords

Search

Navigation